A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer
Condition: Breast Neoplasms Interventions: Drug: Abemaciclib; Drug: Standard Adjuvant ET; Drug: Placebo Sponsor: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Research | Study